Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D E White

Showing results (21-30 of 63) with videos related to

Pageof 7
Sort By:
Emergency Medicine Journal : EMJ|June 29, 2010
Images in emergency medicine. Wegener's granulomatosis: a rare presentationR M Cooper, J D E White, A F Magrath, et al.
American Journal of Clinical Oncology|October 1, 1986
Toxicity studies of adjuvant intravenous versus intraperitoneal 5-FU in patients with advanced primary colon or rectal cancerF J Gianola, P H Sugarbaker, I Barofsky, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 6, 2000
Decreased tolerance to interleukin-2 with repeated courses of therapy in patients with metastatic melanoma or renal cell cancerC E Marroquin, D E White, S M Steinberg, et al.
Cancer|December 1, 1991
Thyroid dysfunction associated with immunotherapy for patients with cancerD J Schwartzentruber, D E White, M H Zweig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1993
Infectious complications associated with interleukin-2 administration: a retrospective review of 935 treatment coursesB A Pockaj, S L Topalian, S M Steinberg, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 15, 1999
Brain metastasis after immunotherapy in patients with metastatic melanoma or renal cell cancer: is craniotomy indicated?R Hurst, D E White, J Heiss, et al.
Blood|June 1, 1987
Hematologic effects of immunotherapy with lymphokine-activated killer cells and recombinant interleukin-2 in cancer patientsS E Ettinghausen, J G Moore, D E White, et al.
American Journal of Ophthalmology|November 1, 1995
Posterior scleritis with annular ciliochoroidal detachmentE M Dodds, C Y Lowder, D A Barnhorst, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Combination chemoimmunotherapy for metastatic colorectal cancer using 5-fluorouracil, leucovorin and interleukin-2J C Yang, E Shlasko, J L Ritchey, et al.
The Journal of Urology|June 24, 1999
Interleukin-2 based immunotherapy for metastatic renal cell carcinoma with the kidney in placeJ R Wagner, M M Walther, W M Linehan, et al.
Pageof 7

Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
Emergency Medicine Journal : EMJ|June 29, 2010
Images in emergency medicine. Wegener's granulomatosis: a rare presentationR M Cooper, J D E White, A F Magrath, et al.
American Journal of Clinical Oncology|October 1, 1986
Toxicity studies of adjuvant intravenous versus intraperitoneal 5-FU in patients with advanced primary colon or rectal cancerF J Gianola, P H Sugarbaker, I Barofsky, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 6, 2000
Decreased tolerance to interleukin-2 with repeated courses of therapy in patients with metastatic melanoma or renal cell cancerC E Marroquin, D E White, S M Steinberg, et al.
Cancer|December 1, 1991
Thyroid dysfunction associated with immunotherapy for patients with cancerD J Schwartzentruber, D E White, M H Zweig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1993
Infectious complications associated with interleukin-2 administration: a retrospective review of 935 treatment coursesB A Pockaj, S L Topalian, S M Steinberg, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 15, 1999
Brain metastasis after immunotherapy in patients with metastatic melanoma or renal cell cancer: is craniotomy indicated?R Hurst, D E White, J Heiss, et al.
Blood|June 1, 1987
Hematologic effects of immunotherapy with lymphokine-activated killer cells and recombinant interleukin-2 in cancer patientsS E Ettinghausen, J G Moore, D E White, et al.
American Journal of Ophthalmology|November 1, 1995
Posterior scleritis with annular ciliochoroidal detachmentE M Dodds, C Y Lowder, D A Barnhorst, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Combination chemoimmunotherapy for metastatic colorectal cancer using 5-fluorouracil, leucovorin and interleukin-2J C Yang, E Shlasko, J L Ritchey, et al.
The Journal of Urology|June 24, 1999
Interleukin-2 based immunotherapy for metastatic renal cell carcinoma with the kidney in placeJ R Wagner, M M Walther, W M Linehan, et al.
Pageof 7